Michæl J. Tobyn
Articles
Carriers for DPIs: formulation and regulatory challenges
October 1st 2006The presence of very low levels of residues (including solvents) in excipients is becoming an important issue for users, and the presence of very low levels of ?non-lactose? species in DPI lactose may pose challenges to suppliers and users.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: November 25th 2024 | Updated: December 23rd 2024
Leveraging Integrated Patient-Centric Innovations When Developing Today’s Biologics
Published: February 23rd 2024 | Updated: December 23rd 2024
Europa Perspectives: Helping to Navigate the Regulatory System
Published: December 13th 2024 | Updated: December 23rd 2024
FDA Creates CDER Center for Real-World Evidence Innovation
Published: December 5th 2024 | Updated: December 23rd 2024
Leveraging Advancements in Bioanalytical Testing
